Colorectal Neoplasms: all 5,734 studies
Page 49 of 58. Open to participants first (1,481), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal CancerCompletedNCT01321957Phase 2
- Geriatric Intervention in Frail Elderly Patients With Colorectal CancerCompletedNCT01321658Not applicable
- Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery PatientsStatus unknownNCT01320319Phase 2/3
- CyberKnife® for Hepatic Metastases From Colorectal CancerTerminatedNCT01318447Phase 2
- Perfusion and Diffusion Magnetic Resonance Imaging, and Phosphorylation of Circulation Endothelial Cells to Determine Anti-anogenic Effect of Chemotherapeutic Regimens in Colorectal Liver Metastasis PatientsCompletedNCT01318239Not applicable
- Epidural Versus Patient-controlled Analgesia for Reduction in Long-term Mortality Following Colorectal Cancer SurgeryTerminatedNCT01318161Phase 3
- Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal CancerTerminatedNCT01317433Not applicable
- FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular ExanthemaStatus unknownNCT01315990Phase 4
- A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal CancerStatus unknownNCT01311050
- Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal CancerStatus unknownNCT01310478Phase 1
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal CancerTerminatedNCT01309126Phase 3
- New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited MetastasesCompletedNCT01307878Phase 3
- A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid TumorsCompletedNCT01306630Phase 1
- Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal CancerStatus unknownNCT01305980Phase 2
- A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal CancerCompletedNCT01304602Phase 1
- Information Needs After Surgery for Colorectal CancerCompletedNCT01303393
- Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression AnastomosisCompletedNCT01301417
- Systems Intervention to Promote Colorectal Cancer (CRC) ScreeningCompletedNCT01299493Not applicable
- IXO+A in mCRC With Liver-only MetastasesWithdrawnNCT01293942Phase 2
- Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal CancerStatus unknownNCT01292681Not applicable
- Dendritic Cell Vaccination for Patients with Solid TumorsCompletedNCT01291420Phase 1/2
- Sorafenib Plus Capecitabine Efficacy Assessment in Patients With Advanced Pre-treated Colorectal CancerCompletedNCT01290926Phase 2
- Trial of FOLF(HA)Iri Versus FOLFIRI in mCRCStatus unknownNCT01290783Phase 3
- A Physician-Based Trial to Increase Colorectal Cancer Screening in ChineseCompletedNCT01289288Phase 1/2
- Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal CancerCompletedNCT01288339Phase 2
- Cancer Stem Cell Markers and Prognostic Markers in Circulating Tumor CellsTerminatedNCT01286883
- A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner SyndromeCompletedNCT01286662
- Colorectal Cancer Detection by Means of Optical FluoroscopyStatus unknownNCT01286064Not applicable
- Pharmacogenomics Study of CPT-11 as the First-line Chemotherapy for mCRCStatus unknownNCT01282658
- Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC)CompletedNCT01281761Phase 2
- Does the Recall by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?Status unknownNCT01279330Not applicable
- Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?Status unknownNCT01279278Not applicable
- 4SC-201 (Resminostat) in Advanced Colorectal CarcinomaCompletedNCT01277406Phase 1/2
- An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Colorectal Cancer (CRONOS 1)TerminatedNCT01277120
- Whey Protein-based Enteral Nutrition Support to Improve Protein Economy in Surgical PatientsCompletedNCT01276795Not applicable
- An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL)TerminatedNCT01276405
- Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal CancerCompletedNCT01274624Phase 1
- Family Colorectal Cancer Awareness and Risk Education Project (Family CARE Project)CompletedNCT01274143Not applicable
- Study of TF2 Carcinoembryonic Antigen (CEA) Antibody in Patients With Metastatic Colorectal CancerWithdrawnNCT01273402Phase 1
- Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal CancerTerminatedNCT01271166Phase 1
- Study of IMMU-130 in Patients With Relapsed/Refractory Colorectal CancerCompletedNCT01270698Phase 1
- Validation of an Alternative Biological Test to Increase the Detection Sensitivity of a Colon TumourCompletedNCT01270360
- Drainage After Rectal Excision for Rectal CancerCompletedNCT01269567Phase 3
- Efficacy of Single Incision (Embryonic NOTES) Laparoscopic Colorectal SurgeryCompletedNCT01269060Phase 2
- An Observational Study of Avastin (Bevacizumab) in Patients With Colorectal CancerCompletedNCT01266564
- Resorbable Barrier for the Prevention of Abdominal and Peri-hepatic Adhesion FormationCompletedNCT01262417Phase 2
- A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver MetastasesCompletedNCT01260415Phase 2
- Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development StudiesCompletedNCT01260168
- Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck CancerStatus unknownNCT01254591Not applicable
- L19TNFα in Patients With Advanced Solid TumorsCompletedNCT01253837Phase 1/2
- Phase 1 and 2 Study of PX-866 and CetuximabCompletedNCT01252628Phase 1/2
- Comparison of Hemoccult, Magstream and OC-Sensor Faecal Occult Blood Tests in Colorectal Cancer ScreeningCompletedNCT01251666Phase 3
- Does Numerical And Pictorial Information On Risk And Benefit Affects The Uptake Of Colorectal Cancer Screening?CompletedNCT01250015
- Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRCStatus unknownNCT01249638Phase 3
- Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal CancerStatus unknownNCT01249521Phase 2
- A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)WithdrawnNCT01245816Phase 3
- Cytokine Changes After Colorectal Cancer ResectionCompletedNCT01244022
- Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal CancerCompletedNCT01243372
- Intermittent Versus Continuous Tarceva StudyCompletedNCT01243047Phase 2
- Oral Green Tea Extract and Milk Thistle Extract to Colorectal Cancer Patients Undergoing ResectionTerminatedNCT01239095Phase 1
- Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)Active, not recruitingNCT01239082Not applicable
- Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal CancerCompletedNCT01238939Phase 1
- Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal CancerStatus unknownNCT01238094Phase 3
- Sexual Dysfunction and the Quality of Sexual Life in Patients With Colorectal Cancer and Their Partners.CompletedNCT01234246
- Radiofrequency Ablation Versus Stereotactic Radiotherapy in Colorectal Liver MetastasesTerminatedNCT01233544Phase 3
- Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.CompletedNCT01229813Phase 3
- Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted TherapyCompletedNCT01225744Phase 2
- Diagnostic Value of C-reactive Protein and White Blood Cell Counts for Early Detection of Inflammatory Complications After Open Resection of Colorectal CancerCompletedNCT01221324
- RSHF in Colorectal CancerCompletedNCT01220063Phase 2
- FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal CancerCompletedNCT01219920Phase 3
- Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer PatientsCompletedNCT01215539Phase 2
- Chemoprevention of Colorectal Cancer: the Role of Non-digestible CarbohydratesStatus unknownNCT01214681Not applicable
- Performance Evaluation of the Micromedic CD24 in Vitro Diagnostic AssayCompletedNCT01214512
- Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate SynthaseCompletedNCT01212718Phase 2
- Study of Circulating Markers in Serum of Patients Treated for Metastatic Colorectal CancerCompletedNCT01212510Not applicable
- Colon Cancer Prevention Using SeleniumStatus unknownNCT01211561Early Phase 1
- The FLU-FOBT Program in Primary Care Settings Where Disparities PersistCompletedNCT01211379Not applicable
- FLU-FIT Program at Kaiser Permanente Northern CaliforniaCompletedNCT01210235Not applicable
- Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal CarcinomaCompletedNCT01208194Phase 2
- Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal CancerCompletedNCT01205711Phase 2
- Presence of Circulating Tumor DNA in Colorectal CancerCompletedNCT01198743
- Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and IIIStatus unknownNCT01196260Phase 2/3
- Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening ProtocolCompletedNCT01196130
- S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal CancerStatus unknownNCT01193452Phase 2
- Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal CancerStatus unknownNCT01190462Phase 2
- A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal CancerCompletedNCT01189942Phase 1
- Clinical Evaluation - A Phase IIA Proof of Concept Study of Regorafenib (Bayer 73-4506) in Biopsy-amenable Asian Colorectal Cancer PatientsStatus unknownNCT01189903Phase 2/3
- Early Removal of Urinary Catheters in Patients After Rectal Surgery: a Prospective StudyCompletedNCT01186237Not applicable
- Lapatinib and Cetuximab in Patients With Solid TumorsCompletedNCT01184482Phase 1
- A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer PatientsCompletedNCT01183494Phase 1
- Re-invitation to Screening Colonoscopy: a Randomized StudyStatus unknownNCT01183156Not applicable
- Information About a Doctor or a Possibility of Choosing Doctor's Gender and Attendance to Screening ColonoscopyCompletedNCT01182922Early Phase 1
- FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal CancerWithdrawnNCT01175291Phase 2
- Endoscopic Treatment of Inoperable Colorectal Cancer With the EndoVe SystemCompletedNCT01172860Phase 1
- Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal CancerCompletedNCT01170299Not applicable
- Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon CancerTerminatedNCT01167725Phase 3
- Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination ChemotherapyCompletedNCT01164215Phase 1
- First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal CancerCompletedNCT01163396Phase 2
- PET-CT and Circulating Tumor Cells in Colorectal CancerCompletedNCT01163305
- Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS TumoursCompletedNCT01161316Phase 2